ROOEY Imaging Technology Corp. Introduces AI-Powered Diagnostic Platform for Cancer Detection

VANCOUVER, British Columbia - May 21, 2025 - PRLog -- ROOEY Imaging Technology Corp. has started the development of an intelligent diagnostic platform to transform how cancer is detected and analyzed in clinical environments. Designed to assist radiologists and oncologists, the upcoming platform will apply artificial intelligence to streamline routine imaging tasks, reduce interpretation time, and improve the accuracy of cancer diagnoses across diverse healthcare systems.

The platform under development by ROOEY Imaging Technology Corp. will feature automated lesion detection, malignancy prediction, and standardized analysis workflows. Future functionality includes real-time collaboration tools, telemedicine integration, and augmented reality-based image annotation to support clinical decision-making. The system will be structured to support high-capacity urban hospitals and smaller clinics with limited diagnostic infrastructure—bridging gaps in access and expertise.

ROOEY Imaging Technology Corp. plans to deliver its platform through a flexible SaaS model with modular AI features that can be customized to institutional needs. With a focus on clinical efficiency, ethical AI development, and improved patient outcomes, ROOEY Imaging Technology Corp. aims to equip healthcare providers with the tools needed to offer faster, fairer, and more consistent diagnostic services in the fight against cancer.

About ROOEY Imaging Technology Corp.: ROOEY is a forward-thinking healthcare technology company specializing in advancing the detection and diagnosis of cancer through sophisticated AI-driven solutions. Learn more at https://rooeytech.com/.